BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21465002)

  • 21. ['Medical technology assessment'; more than just efficacy].
    Buskens E
    Ned Tijdschr Geneeskd; 2000 Mar; 144(13):622-6. PubMed ID: 10761552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implementing and using quality measures for children's health care: perspectives on the state of the practice.
    Shaller D
    Pediatrics; 2004 Jan; 113(1 Pt 2):217-27. PubMed ID: 14702504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Introducing new mechanical ventilation technology: the hospital perspective.
    Kacmarek RM
    Respir Care; 1995 Sep; 40(9):947-51. PubMed ID: 10152238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness analysis and innovation.
    Jena AB; Philipson TJ
    J Health Econ; 2008 Sep; 27(5):1224-36. PubMed ID: 18619695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The medical technologist and evaluation of health technologies.
    Peddecord KM
    Am J Med Technol; 1980 Jan; 46(1):30-2. PubMed ID: 7352464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Striking a balance on new technology. Cost-effectiveness analysis can help sort out emerging health care technologies, but what are the consequences for continued medical innovation?
    Philipson TJ; Jena AB
    AHIP Cover; 2006; 47(5):29, 31, 33. PubMed ID: 17007325
    [No Abstract]   [Full Text] [Related]  

  • 27. Joint report of the Council on Scientific Affairs and the Council on Medical Service. Technology assessment in medicine.
    Arch Intern Med; 1992 Jan; 152(1):46-50. PubMed ID: 1728928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Technology as culprit and benefactor.
    Wilensky GR
    Q Rev Econ Bus; 1990; 30(4):45-53. PubMed ID: 10113534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost modeling to justify technology acquisitions.
    Vanden Brink J; Gray S
    Healthc Financ Manage; 1997 Jun; 51(6):72-6. PubMed ID: 10167845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating technology under changing financing arrangements.
    Luce BR
    Trustee; 1986 Aug; 39(8):15-7. PubMed ID: 10311653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Technology assessment and the doctor-patient relationship.
    Wax AL
    Va Law Rev; 1996 Nov; 82(8):1641-62. PubMed ID: 16715567
    [No Abstract]   [Full Text] [Related]  

  • 32. Assessment of the effectiveness of supply-side cost-containment measures.
    Garrison LP
    Health Care Financ Rev Annu Suppl; 1991; ():13-20. PubMed ID: 10117115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Understanding health technology assessment.
    Craig AM
    Med Device Technol; 2000 Sep; 11(7):32-7. PubMed ID: 15326744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New medical technology diffusion key element in health cost increases.
    Brown E
    Physician Exec; 1996 Jan; 22(1):56-7. PubMed ID: 10155967
    [No Abstract]   [Full Text] [Related]  

  • 35. Cost-effectiveness analysis in the assessment of diagnostic imaging technologies.
    Gazelle GS; McMahon PM; Siebert U; Beinfeld MT
    Radiology; 2005 May; 235(2):361-70. PubMed ID: 15858079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost escalation in health-care technology--possible solutions.
    Járos GG; Boonzaier DA
    S Afr Med J; 1993 Jun; 83(6):420-2. PubMed ID: 8211460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health technology assessment: problems and challenges.
    Abrams HL; Hessel S
    AJR Am J Roentgenol; 1987 Dec; 149(6):1127-32. PubMed ID: 3500599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can technology assessment control health spending?
    Garber AM
    Health Aff (Millwood); 1994; 13(3):115-26. PubMed ID: 7927142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colliding forces in radiology: technologic imperative, resource limitations, and accountability demands.
    Hendee WR; Brown EF; Stanley RJ; Thrall JH; Zylak CJ
    Radiographics; 1994 May; 14(3):647-53; discussion 654-5. PubMed ID: 8066277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Principles of cost effectiveness analysis for the assessment of current and new therapies.
    Hillner BE; Smith TJ; Desch CE
    J Hematother; 1993; 2(4):501-6. PubMed ID: 8087498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.